Filing Details
- Accession Number:
- 0001209191-22-051669
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-30 17:15:33
- Reporting Period:
- 2022-08-16
- Accepted Time:
- 2022-09-30 17:15:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1490829 | James Jones | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-16 | 32 | $2.35 | 23,287 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-17 | 32 | $2.31 | 23,319 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-18 | 32 | $2.23 | 23,351 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-19 | 32 | $2.35 | 23,383 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-22 | 32 | $2.51 | 23,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-23 | 32 | $2.59 | 23,447 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-24 | 32 | $2.59 | 23,479 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-25 | 32 | $2.62 | 23,511 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-26 | 32 | $2.55 | 23,543 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-29 | 34 | $2.44 | 23,577 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-30 | 34 | $2.38 | 23,611 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-31 | 34 | $2.36 | 23,645 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-01 | 34 | $2.39 | 23,679 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-02 | 34 | $2.42 | 23,713 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-06 | 34 | $2.15 | 23,747 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-07 | 34 | $2.24 | 23,781 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-08 | 34 | $2.22 | 23,815 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-09 | 29 | $2.21 | 23,844 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-12 | 34 | $2.46 | 23,878 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-13 | 34 | $2.45 | 23,912 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-14 | 34 | $2.51 | 23,946 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-15 | 34 | $2.47 | 23,980 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-16 | 34 | $2.49 | 24,014 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-19 | 31 | $2.56 | 24,045 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-20 | 31 | $2.54 | 24,076 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-21 | 31 | $2.59 | 24,107 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-22 | 31 | $2.51 | 24,138 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-23 | 31 | $2.55 | 24,169 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-26 | 31 | $2.49 | 24,200 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-27 | 31 | $2.57 | 24,231 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.